sponsored by Deloitte
Posted:  04 Sep 2009
Published:  03 Sep 2009
Format:  PDF
Length:  15  Page(s)
Type:  White Paper
Language:  English
ABSTRACT:
Analyze the companies that are moving assertively toward International Financial Reporting Standards (IFRS), and you’ll note several predominant characteristics. Most have global operations, complex organizational structures, and aggressive competition. They are often publicly held. And they frequently are known for innovation and leadership. In other words, they sound a lot like a global life sciences company. This publication "IFRS in the Life Sciences: Broad Implications" provides practical industry insights on IFRS for life science executives and includes useful sections on: IFRS challenges and opportunities in life sciences; Implications of IFRS for financial reporting, tax, human resources, mergers and acquisitions, IT, and treasury; Key actions steps for life science executives; Approaches to IFRS conversion; Key differences between IFRS and U.S. Generally Accepted Accounting Principles (GAAP) for the life science industry.





BROWSE RELATED RESOURCES
Compliance (Finance) | Compliance Audits | Compliance Best Practices | Financial Reporting | Financial Systems | Governance, Risk, Compliance (GRC) | Life Sciences Industry | Risk Management | Standards

View All Resources sponsored by Deloitte

About TechTarget:

TechTarget provides enterprise IT professionals with the information they need to perform their jobs - from developing strategy, to making cost-effective IT purchase decisions and managing their organizations' IT projects - with its network of technology-specific Web sites, events and magazines

All Rights Reserved, Copyright 2000 - 2014, TechTarget | Read our Privacy Statement